SOURCE: VIVUS, Inc.

VIVUS, Inc.

April 10, 2015 07:00 ET

VIVUS to Present at Upcoming Investor Conference

MOUNTAIN VIEW, CA--(Marketwired - April 10, 2015) - VIVUS, Inc. (NASDAQ: VVUS) today announced that management will present an overview of the company at the following investment conference:

14th Annual Needham Healthcare Conference
April 14, 2015, 3:40pm EDT
The Westin Grand Central Hotel, New York, NY

A live webcast and 30-day archive of the presentation will be available at http://ir.vivus.com.

About VIVUS

VIVUS is a biopharmaceutical company commercializing and developing innovative, next-generation therapies to address unmet needs in obesity, sleep apnea, diabetes and sexual health. For more information about the company, please visit www.vivus.com.

Certain statements in this press release are forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. These statements may be identified by the use of forward-looking words such as "anticipate," "believe," "forecast," "estimate," "expect," "intend," "likely," "may," "plan," "potential," "predict," "opportunity" and "should," among others. There are a number of factors that could cause actual events to differ materially from those indicated by such forward-looking statements. VIVUS does not undertake an obligation to update or revise any forward-looking statements. Investors should read the risk factors set forth in VIVUS's Form 10-K for the year ended December 31, 2014 as filed on February 25, 2015 and periodic reports filed with the Securities and Exchange Commission.

Contact Information